Clinical Trial Update: Decitabine, Cytarabine, and Daunorubicin Hydrochloride in Treating Patients With Acute Myeloid Leukemia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the combination of decitabine, cytarabine, and daunorubicin hydrochloride for acute myeloid leukemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• decitabine, cytarabine, and daunorubicin hydrochloride

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Acute Myeloid Leukemia, Adult Acute Basophilic Leukemia | Phase 2 | Status: ACTIVE_NOT_RECRUITING